Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET.

Oliver GoldhardtInanna WarnhoffIgor YakushevIlijana BegcevicHans FörstlViktor MagdolenAntoninus SoosaipillaiEleftherios DiamandisPanagiotis AlexopoulosTimo Grimmer

Published in: Translational neurodegeneration (2019)

KLK6 deserves further investigations as a potential biomarker of Tau pathology in AD.

Keyphrases

cerebrospinal fluid
pet ct
positron emission tomography
pet imaging
computed tomography
cognitive decline
mild cognitive impairment